|
OMIM |
Link |
Information gain |
01 |
|
gout susceptibility 1
|
[NCBI]
|
0.0110626
|
|
|
urate-binding globulin, decrease in
|
[NCBI]
|
0.00230594
|
|
|
hypouricemia, renal
|
[NCBI]
|
0.00177133
|
|
|
HNFJ
|
[NCBI]
|
0.00144324
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
0.00136467
|
|
|
MCKD1
|
[NCBI]
|
0.00122704
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
0.00117372
|
|
|
XDH
|
[NCBI]
|
0.00105541
|
|
|
xanthinuria, type i
|
[NCBI]
|
0.00101221
|
|
|
gout, hprt-related
|
[NCBI]
|
0.000749053
|
|
|
hypouricemia, familial renal, due to tubular hypersecretion
|
[NCBI]
|
0.000566925
|
|
|
HPRT1
|
[NCBI]
|
0.000475481
|
|
|
UOX
|
[NCBI]
|
0.000441166
|
|
|
LNS
|
[NCBI]
|
0.000329512
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
0.000283101
|
|
|
hirsutism--skeletal dysplasia--mental retardation syndrome
|
[NCBI]
|
0.000283101
|
|
|
uric acid urolithiasis
|
[NCBI]
|
0.000283101
|
|
|
APRT
|
[NCBI]
|
0.00023999
|
|
|
SLC22A12
|
[NCBI]
|
0.000177344
|
|
|
ALMS
|
[NCBI]
|
0.000164658
|
|
|
lactic acidosis, chronic adult form
|
[NCBI]
|
0.000141461
|
|
|
hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase
|
[NCBI]
|
0.000141461
|
|
|
hypouricemia, hypercalcinuria, and decreased bone density
|
[NCBI]
|
0.000141461
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
0.000127225
|
|
|
FPLD2
|
[NCBI]
|
0.000121771
|
|
|
syringomas, multiple
|
[NCBI]
|
0.000109916
|
|
|
glycogen storage disease i
|
[NCBI]
|
0.000107302
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
8.00852e-05
|
|
|
GVM
|
[NCBI]
|
8.00852e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
8.00852e-05
|
|
|
GLYS1
|
[NCBI]
|
7.63151e-05
|
|
|
SLE
|
[NCBI]
|
7.61495e-05
|
|
|
PRPS1
|
[NCBI]
|
7.61056e-05
|
|
|
NP
|
[NCBI]
|
7.28522e-05
|
|
|
CAT
|
[NCBI]
|
7.01371e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
6.77926e-05
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
6.55557e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
6.50235e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
5.65346e-05
|
|
|
CCAL2
|
[NCBI]
|
5.30089e-05
|
|
|
RA
|
[NCBI]
|
5.23807e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
4.36176e-05
|
|
|
ADSL
|
[NCBI]
|
4.24838e-05
|
|
|
FCHL
|
[NCBI]
|
4.1474e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
4.08075e-05
|
|
|
homocysteinemia
|
[NCBI]
|
4.01627e-05
|
|
|
MIRN368
|
[NCBI]
|
3.8312e-05
|
|
|
MIRN376A-2
|
[NCBI]
|
3.8312e-05
|
|
|
MIRN376A-1
|
[NCBI]
|
3.8312e-05
|
|
|
MIRN376B
|
[NCBI]
|
3.8312e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
3.77752e-05
|
|
|
CDG1A
|
[NCBI]
|
3.46676e-05
|
|
|
EGF
|
[NCBI]
|
3.09054e-05
|
|
|
solute carrier family 22 (organic anion/cation transporter), member 11
|
[NCBI]
|
3.08927e-05
|
|
|
PSORS1
|
[NCBI]
|
2.8603e-05
|
|
|
PTH
|
[NCBI]
|
2.81407e-05
|
|
|
ZNF365
|
[NCBI]
|
2.80949e-05
|
|
|
ALB
|
[NCBI]
|
2.57849e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
2.57542e-05
|
|
|
STX16
|
[NCBI]
|
2.49306e-05
|
|
|
GDA
|
[NCBI]
|
2.2964e-05
|
|
|
APS1
|
[NCBI]
|
2.16396e-05
|
|
|
CP
|
[NCBI]
|
2.14824e-05
|
|
|
NLRP3
|
[NCBI]
|
1.94835e-05
|
|
|
AGXT
|
[NCBI]
|
1.80129e-05
|
|
|
MPO
|
[NCBI]
|
1.62422e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
1.5929e-05
|
|
|
CD8A
|
[NCBI]
|
1.51357e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.51357e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.37036e-05
|
|
|
TTR
|
[NCBI]
|
1.21649e-05
|
|
|
GAMT
|
[NCBI]
|
1.2164e-05
|
|
|
UMOD
|
[NCBI]
|
1.13234e-05
|
|
|
SHBG
|
[NCBI]
|
9.12501e-06
|
|
|
HP
|
[NCBI]
|
8.13005e-06
|
|
|
PF4
|
[NCBI]
|
7.61039e-06
|
|
|
DDC
|
[NCBI]
|
6.86167e-06
|
|
|
ACHE
|
[NCBI]
|
6.68705e-06
|
|
|
CCK
|
[NCBI]
|
4.68185e-06
|
|
|
ABP1
|
[NCBI]
|
4.65472e-06
|
|
|
VEGF
|
[NCBI]
|
3.98326e-06
|
|
|
CVID
|
[NCBI]
|
3.55118e-06
|
|
|
AKR1B1
|
[NCBI]
|
3.46e-06
|
|
|
APOB
|
[NCBI]
|
3.39997e-06
|
|
|
NPPA
|
[NCBI]
|
2.58861e-06
|
|
|
AFP
|
[NCBI]
|
2.17276e-06
|
|
|
ABCC1
|
[NCBI]
|
2.00444e-06
|
|
|
ADA
|
[NCBI]
|
1.8956e-06
|
|
|
MDD
|
[NCBI]
|
1.73457e-06
|
|
|
LPL
|
[NCBI]
|
1.70991e-06
|
|
|
MB
|
[NCBI]
|
1.52399e-06
|
|
|
KLK3
|
[NCBI]
|
1.48771e-06
|
|
|
TH
|
[NCBI]
|
1.33125e-06
|
|
|
CYP1A1
|
[NCBI]
|
1.22948e-06
|
|
|
TNF
|
[NCBI]
|
9.9817e-07
|
|
|
CHAT
|
[NCBI]
|
9.83304e-07
|
|
|
CF
|
[NCBI]
|
9.07256e-07
|
|
|
EPO
|
[NCBI]
|
6.54008e-07
|
|
|
COMT
|
[NCBI]
|
5.0353e-07
|
|
|
AVP
|
[NCBI]
|
3.97621e-07
|
|
|
RNASE3
|
[NCBI]
|
1.8717e-07
|
|
|
SPP1
|
[NCBI]
|
1.36977e-07
|
|
|
FMF
|
[NCBI]
|
1.09014e-07
|
|
|
VDR
|
[NCBI]
|
3.86647e-08
|
|
|
APOE
|
[NCBI]
|
3.71651e-11
|
|
|
MBP
|
[NCBI]
|
1.82494e-11
|
|
|
PTK2
|
[NCBI]
|
5.61819e-12
|
|